KalVista Pharmaceuticals Announced Transfer or Voluntary Withdrawal of Listing

KalVista Pharmaceuticals announced the voluntary withdrawal of its listing from The Nasdaq Global Market. Following the completion of a merger, the company requested trading suspension and filed Form 25 to remove its shares. Trading ceased on June 11, 2026, prior to market open. The company also intends to file Form 15 to terminate SEC registration and suspend reporting obligations.

On June 11, 2026, the company notified Nasdaq of the merger’s completion, requested suspension of trading, and asked Nasdaq to file a Form 25 to remove its shares from The Nasdaq Global Market. Trading ceased prior to the June 11 market open, and the company intends to file Form 15 to terminate registration and suspend reporting obligations.

Original SEC Filing: KalVista Pharmaceuticals, Inc. [ KALV ] - 8-K - Jun. 11, 2026

Disclaimer

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.